nach oben

Internal and Emergency Medicine

Erschienen in:

06.12.2018 | IM-COMMENTARY

Chronic kidney disease in low-middle income populations: a call to action for screening and prevention

verfasst von: Anna Paini, Massimo Salvetti, Silvio Caligaris, Francesco Castelli, Maria Lorenza Muiesan

Erschienen in: Internal and Emergency Medicine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

It has been estimated that about 5–10 million people die each year from kidney disease. The incidence and the prevalence of chronic kidney disease (CKD) are increasing worldwide. The true burden of kidney disease should be better assessed and prevented; in fact this worldwide health problem is probably underestimated, because of the relative lack of epidemiological data, the poor awareness of the problem, and the limited access to laboratory examinations for most of the general population in low-middle income countries [1‐4]. A recent analysis of all the available studies published between 2008 and 2014, reporting the prevalence of CKD in Nigeria, finds a high prevalence of CKD in the country, ranging from 2.5 to 26%, with a high variability according to the examined population, but probably also influenced by the equation used to estimate the glomerular filtration rate (GFR) [5]. …

Murray CJL, The GBD 2016 Mortality Collaborators (2017) Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1084–1150CrossRef

Murray CJL, The GBD 2016 Causes of Death Collaborators (2017) Global, regional, and national age–sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1151–1210CrossRef

Rossier C, Soura AB, Duthé G, Findley S (2014) Non-communicable disease mortality and risk factors in formal and informal neighborhoods, ouagadougou, burkina faso: evidence from a health and demographic surveillance system. PLoS One 9(12):113780CrossRef

Perico N, Remuzzi G (2016) Prevention programs for chronic kidney disease in low-income countries. Intern Emerg Med 11:385–389CrossRefPubMed

Chukwuonye II, Ogah OS, Anyabolu EN, Ohagwu KA, Nwabuko OC, Onwuchekwa U, Chukwuonye ME, Obi EC, Oviasu E (2018) Prevalence of chronic kidney disease in Nigeria: systematic review of population-based studies. Int J Nephrol Renovasc Dis 22(11):165–172CrossRef

Kassebaum NJ, Arora M, Barber RM, Bhutta ZA, Brown J, Carter A et al (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1603–1658CrossRef

Agyemang C, de-Graft Aikins A, Bhopal R (2012) Ethnicity and cardiovascular health research: pushing the boundaries by including comparison populations in the countries of origin. Ethn Health 17:579–596CrossRefPubMed

Modesti PA, Bianchi S, Borghi C, Cameli M, Capasso G, Ceriello A et al (2014) Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med 15(9):683–692CrossRef

Montesi L, Turchese Caletti M, Marchesini G (2016) Diabetes in migrants and ethnic minorities in a changing world. World J Diabetes 7(3):34–44CrossRefPubMedPubMedCentral

10.

Animaw W, Seyoum Y (2017) Increasing prevalence of diabetes mellitus in a developing country and its related factors. PLoS One 12(11):e0187670CrossRefPubMedPubMedCentral

11.

Stanifer JW, Muiru A, Jafar TH, Patel UD (2016) Chronic kidney disease in low- and middle-income countries. Nephrol Dial Transplant 31:868–874CrossRefPubMedPubMedCentral

12.

Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V (2017) Chronic kidney disease and the global NCDs agenda. BMJ Glob Health. 2:e000380CrossRefPubMedPubMedCentral

13.

Peer N (2015) The converging burdens of infectious and non-communicable diseases in rural-to-urban migrant Sub-Saharan African populations: a focus on HIV/AIDS, tuberculosis and cardio-metabolic diseases. Travel Dis Travel Med Vac 1:6CrossRef

14.

Hodel NC, Hamad A, Praehauser C, Mwangoka G, Kasella IM, Reither K, Abdulla S, Hatz CFR, Mayr M (2018) The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa. PLoS One 13(10):e0205326CrossRefPubMedPubMedCentral

15.

Luyckx V, Tonelli M, Stanifer JW (2018) The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96:414C–422CCrossRef

16.

Stronks K, Snijder MB, Peters RJG, Prins M, Schene AH, Zwinderman AH (2013) Unravelling the impact of ethnicity on health in Europe: the HELIUS study. BMC Public Health 13:402CrossRefPubMedPubMedCentral

17.

Agyemang C, Snijder MB, Adjei DN, van den Born BJ, Modesti PA, Peters RJ, Stronks K, Vogt L (2016) Ethnic disparities in CKD in the Netherlands: the healthy life in an urban setting (HELIUS) study. Am J Kidney Dis 67(3):391–399CrossRefPubMed

18.

Adjei DN, Stronks K, Adu D, Snijder MB, Modesti PA, Peters RJG, Vogt L, Agyemang C (2017) Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample—the HELIUS study. PLoS One 12(11):e0186460CrossRefPubMedPubMedCentral

19.

Shoham DA, Vupputuri S, Kshirsagar AV (2005) Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis 12(1):56–63CrossRefPubMed

20.

Bello AK, Peters J, Rigby J, Rahman AA, El Nahas M (2008) Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol 3(5):1316–1323CrossRefPubMedPubMedCentral

21.

Ibrahim MM, Damasceno A (2012) Hypertension in developing countries. Lancet 380:611–619CrossRefPubMed

22.

Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S et al (2016) Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS One 11(1):e0147601CrossRefPubMedPubMedCentral

23.

Banerjee D, Plange-Rhule J, Chitalia N, Kumi K, Micah FB, Cappuccio FP, Eastwood JB (2018) Pulse pressure relationships with demographics and kidney function in Ashanti, Ghana. Int J Hypertens 4(2018):7864564

24.

Udler MS, Nadkarni GN, Belbin G, Lotay V, Wyatt C, Gottesman O, Bottinger EP, Kenny EE, Peter I (2015) Effect of genetic African ancestry on eGFR and kidney disease. J Am Soc Nephrol 26(7):1682–1692CrossRefPubMed

25.

Nannan Panday R, Haan Y, Diemer F, Punwasi A, Rommy C, Heerenveen I, van Montfrans GA, Brewster LM (2018) Chronic kidney disease and kidney health care status: the healthy life in Suriname (HeliSur) study. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1962-3

26.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I, List of Authors/Task Force Members (2018) 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 36(12):2284–2309CrossRefPubMed

27.

Doshi SM, Friedman AN (2017) Diagnosis and management of type 2 diabetic kidney disease. Clin J Am Soc Nephrol 12(8):1366–1373. https://doi.org/10.2215/CJN.11111016 (Epub 2017 Mar 9) CrossRefPubMedPubMedCentral

28.

Viazzi F, Leoncini G, Grassi G, Pontremoli R (2018) Antihypertensive treatment and renal protection: is there a J-curve relationship? J Clin Hypertens (Greenwich) 20(11):1560–1574CrossRef

29.

Liyanage T, Ninomiya T, Jha V et al (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982CrossRefPubMed

30.

Cappuccio FP, Miller MA (2016) Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med 11:299–305CrossRefPubMedPubMedCentral

31.

George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP (2017) Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health 2(2):e000256CrossRefPubMedPubMedCentral

Titel: Chronic kidney disease in low-middle income populations: a call to action for screening and prevention
verfasst von: Anna Paini
Massimo Salvetti
Silvio Caligaris
Francesco Castelli
Maria Lorenza Muiesan
Publikationsdatum: 06.12.2018
Verlag: Springer International Publishing
Erschienen in: Internal and Emergency Medicine / Ausgabe 2/2019
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-018-2005-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Potential drug–drug interactions in deceased inpatients

Central venous oxygen saturation is not predictive of early complications in cancer patients presenting to the emergency department

Effect of the Pulmonary Embolism Rule-Out Criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial

Risk factors associated with bacteremia correlated with mortality in patients with acute bacterial skin and skin structure infection

Chronic kidney disease and kidney health care status: the healthy life in Suriname (HeliSur) study